Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1459

1.

Quantitative Characterization of the Regulation of Iron Metabolism in Glioblastoma Stem-Like Cells using Magnetophoresis.

Park KJ, Kim J, Testoff T, Adams J, Poklar M, Zborowski M, Venere M, Chalmers JJ.

Biotechnol Bioeng. 2019 Mar 24. doi: 10.1002/bit.26973. [Epub ahead of print]

PMID:
30906984
2.

Bronchiectasis insanity: Doing the same thing over and over again and expecting different results?

Metersky M, Chalmers J.

F1000Res. 2019 Mar 15;8. pii: F1000 Faculty Rev-293. doi: 10.12688/f1000research.17295.1. eCollection 2019. Review.

PMID:
30906533
3.

Blood pressure variability and outcome in acute ischemic and hemorrhagic stroke: a post hoc analysis of the HeadPoST study.

Minhas JS, Wang X, Lavados PM, Moullaali TJ, Arima H, Billot L, Hackett ML, Olavarria VV, Middleton S, Pontes-Neto O, De Silva HA, Lee TH, Pandian JD, Mead GE, Watkins C, Chalmers J, Anderson CS, Robinson TG; HeadPoST Investigators.

J Hum Hypertens. 2019 Mar 20. doi: 10.1038/s41371-019-0193-z. [Epub ahead of print]

PMID:
30894658
4.

Infratentorial Intracerebral Hemorrhage.

Chen R, Wang X, Anderson CS, Robinson T, Lavados PM, Lindley RI, Chalmers J, Delcourt C; INTERACT Investigators.

Stroke. 2019 Mar 20:STROKEAHA118023766. doi: 10.1161/STROKEAHA.118.023766. [Epub ahead of print]

PMID:
30890109
5.

Navigating the landscape of core outcome set development in dermatology.

Prinsen CA, Spuls PI, Kottner J, Thomas K, Apfelbacher C, Chalmers J, Deckert S, Furue M, Gerbens L, Kirkham J, Simpson E, Alam M, Balzer K, Beeckman D, Eleftheriadou V, Ezzedine K, Horbach SE, Ingram JR, Layton A, Weller K, Wild T, Wolkerstorfer A, Williams H, Schmitt J.

J Am Acad Dermatol. 2019 Mar 13. pii: S0190-9622(19)30423-2. doi: 10.1016/j.jaad.2019.03.009. [Epub ahead of print]

PMID:
30878565
6.

C-peptide predicts all-cause and cardiovascular death in a cohort of individuals with newly diagnosed type 2 diabetes. The Skaraborg diabetes register.

Pikkemaat M, Andersson T, Melander O, Chalmers J, Rådholm K, Bengtsson Boström K.

Diabetes Res Clin Pract. 2019 Mar 13;150:174-183. doi: 10.1016/j.diabres.2019.03.014. [Epub ahead of print]

PMID:
30878389
7.

A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults.

Crichton ML, Aliberti S, Chalmers JD.

Eur Respir Rev. 2019 Mar 14;28(151). pii: 180108. doi: 10.1183/16000617.0108-2018. Print 2019 Mar 31. Review.

8.

Patients' understanding of cellulitis and their information needs: a mixed-methods study in primary and secondary care.

Teasdale E, Lalonde A, Muller I, Chalmers J, Smart P, Hooper J, El-Gohary M, Thomas KS, Santer M.

Br J Gen Pract. 2019 Mar 11. pii: bjgp19X701873. doi: 10.3399/bjgp19X701873. [Epub ahead of print]

PMID:
30858335
9.

The Burden of Childhood Atopic Dermatitis in the Primary Care Setting: A Report from the Meta-LARC Consortium.

Al-Naqeeb J, Danner S, Fagnan LJ, Ramsey K, Michaels L, Mitchell J, Branca K, Morris C, Nease DE Jr, Zittleman L, Levy B, Daly J, Hahn D, Dolor RJ, Williams HC, Chalmers JR, Hanifin J, Tofte S, Zuckerman KE, Hansis K, Gundersen M, Block J, Karr F, Dunbrasky S, Siebe K, Dillon K, Cibotti R, Lapidus J, Simpson EL.

J Am Board Fam Med. 2019 Mar-Apr;32(2):191-200. doi: 10.3122/jabfm.2019.02.180225.

10.

Assessing an acutely disturbed person in the community.

O'Brien A, Kaar S, Ibison J, Chalmers J.

BMJ. 2019 Mar 7;364:l578. doi: 10.1136/bmj.l578. No abstract available.

PMID:
30846425
11.

Healthcare-asociated pneumonia:Any reasons to still utilize this label in 2019?

Ewig S, Kolditz M, Pletz MW, Chalmers J.

Clin Microbiol Infect. 2019 Feb 27. pii: S1198-743X(19)30090-4. doi: 10.1016/j.cmi.2019.02.022. [Epub ahead of print] Review.

PMID:
30825674
12.

The economic burden of bronchiectasis - known and unknown: a systematic review.

Goeminne PC, Hernandez F, Diel R, Filonenko A, Hughes R, Juelich F, Solomon GM, Upton A, Wichmann K, Xu W, Chalmers JD.

BMC Pulm Med. 2019 Feb 28;19(1):54. doi: 10.1186/s12890-019-0818-6.

13.

EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes.

Zhang Z, Tremblay J, Raelson J, Sofer T, Du L, Fang Q, Argos M, Marois-Blanchet FC, Wang Y, Yan L, Chalmers J, Woodward M, Harrap S, Hamet P, Luo H, Wu J.

J Hypertens. 2019 Apr;37(4):775-789. doi: 10.1097/HJH.0000000000001948.

PMID:
30817459
14.

Helping physicians to keep abreast of the medical literature: Andrew Duncan and Medical and Philosophical Commentaries, 1773-1795.

Chalmers J, Chalmers I, Troehler U.

J R Soc Med. 2019 Jan;112(1):36-47. doi: 10.1177/0141076818820779. No abstract available.

PMID:
30798721
15.

The National Institute for Health Research Hyperacute Stroke Research Centres and the ENCHANTED trial: the impact of enhanced research infrastructure on trial metrics and patient outcomes.

Robinson TG, Wang X, Durham AC, Ford GA, Liao J, Littlewood S, Roffe C, White P, Chalmers J, Anderson CS; ENCHANTED Investigators.

Health Res Policy Syst. 2019 Feb 13;17(1):19. doi: 10.1186/s12961-019-0417-2.

16.

More on Causal Inference Studies.

Lederer DJ, Bell SC, Smyth AR, Chalmers JD.

Ann Am Thorac Soc. 2019 Feb 11. doi: 10.1513/AnnalsATS.201901-070LE. [Epub ahead of print] No abstract available.

PMID:
30742489
17.

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.

Anderson CS, Huang Y, Lindley RI, Chen X, Arima H, Chen G, Li Q, Billot L, Delcourt C, Bath PM, Broderick JP, Demchuk AM, Donnan GA, Durham AC, Lavados PM, Lee TH, Levi C, Martins SO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Silva F, Song L, Thang NH, Wardlaw JM, Wang JG, Wang X, Woodward M, Chalmers J, Robinson TG; ENCHANTED Investigators and Coordinators.

Lancet. 2019 Mar 2;393(10174):877-888. doi: 10.1016/S0140-6736(19)30038-8. Epub 2019 Feb 7.

PMID:
30739745
18.

Children in Social Research: Do Higher Payments Encourage Participation in Riskier Studies?

Taplin S, Chalmers J, Hoban B, McArthur M, Moore T, Graham A.

J Empir Res Hum Res Ethics. 2019 Apr;14(2):126-140. doi: 10.1177/1556264619826796. Epub 2019 Feb 8.

PMID:
30735083
19.

Defining and measuring "eczema control": An international qualitative study to explore the views of those living with and treating atopic eczema.

Howells L, Thomas KS, Sears AV, Nasr I, Wollenberg A, Schuttelaar MLA, Romeijn GLE, Paller AS, Mueller K, Doytcheva K, Kataoka Y, Daguze J, Barbarot S, von Kobyletzki LB, Beckman L, Ratib S, Cowdell F, Santer M, Chalmers JR; long-term control of eczema working group for the HOME initiative.

J Eur Acad Dermatol Venereol. 2019 Feb 5. doi: 10.1111/jdv.15475. [Epub ahead of print]

PMID:
30720903
20.

Challenges in severe community-acquired pneumonia: a point-of-view review.

Torres A, Chalmers JD, Dela Cruz CS, Dominedò C, Kollef M, Martin-Loeches I, Niederman M, Wunderink RG.

Intensive Care Med. 2019 Feb;45(2):159-171. doi: 10.1007/s00134-019-05519-y. Epub 2019 Jan 31. Review.

PMID:
30706119
21.

British Thoracic Society guideline for bronchiectasis in adults.

Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn JS, Floto RA, Grillo L, Gruffydd-Jones K, Harvey A, Haworth CS, Hiscocks E, Hurst JR, Johnson C, Kelleher WP, Bedi P, Payne K, Saleh H, Screaton NJ, Smith M, Tunney M, Whitters D, Wilson R, Loebinger MR.

BMJ Open Respir Res. 2018 Dec 28;5(1):e000348. doi: 10.1136/bmjresp-2018-000348. eCollection 2018.

22.

Measuring Unmet Demand for Alcohol and Other Drug Treatment: The Application of an Australian Population-Based Planning Model.

Ritter A, Chalmers J, Gomez M.

J Stud Alcohol Drugs Suppl. 2019 Jan;Sup 18:42-50.

PMID:
30681948
23.

Key Considerations in Planning for Substance Use Treatment: Estimating Treatment Need and Demand.

Ritter A, Mellor R, Chalmers J, Sunderland M, Lancaster K.

J Stud Alcohol Drugs Suppl. 2019 Jan;Sup 18:22-30.

PMID:
30681945
24.

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.

Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE.

Lancet Respir Med. 2019 Mar;7(3):213-226. doi: 10.1016/S2213-2600(18)30427-2. Epub 2019 Jan 15. Erratum in: Lancet Respir Med. 2019 Jan 25;:.

PMID:
30658914
25.

The evolution of the European Respiratory Journal: volume 2.

Chalmers JD, Kolb M.

Eur Respir J. 2019 Jan 17;53(1). pii: 1802459. doi: 10.1183/13993003.02459-2018. Print 2019 Jan. No abstract available.

PMID:
30655453
26.

Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.

Berkelmans GFN, Gudbjörnsdottir S, Visseren FLJ, Wild SH, Franzen S, Chalmers J, Davis BR, Poulter NR, Spijkerman AM, Woodward M, Pressel SL, Gupta AK, van der Schouw YT, Svensson AM, van der Graaf Y, Read SH, Eliasson B, Dorresteijn JAN.

Eur Heart J. 2019 Jan 9. doi: 10.1093/eurheartj/ehy839. [Epub ahead of print]

PMID:
30629157
27.

Single cell analysis of aged RBCs: quantitative analysis of the aged cells and byproducts.

Kim J, Weigand M, Palmer AF, Zborowski M, Yazer MH, Chalmers JJ.

Analyst. 2019 Jan 28;144(3):935-942. doi: 10.1039/c8an01904e.

PMID:
30617361
28.

Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.

Ohkuma T, Jun M, Rodgers A, Cooper ME, Glasziou P, Hamet P, Harrap S, Mancia G, Marre M, Neal B, Perkovic V, Poulter N, Williams B, Zoungas S, Chalmers J, Woodward M; ADVANCE Collaborative Group.

Hypertension. 2019 Jan;73(1):84-91. doi: 10.1161/HYPERTENSIONAHA.118.12060.

PMID:
30571562
29.

British Thoracic Society Guideline for bronchiectasis in adults.

Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn SJ, Floto AR, Grillo L, Gruffydd-Jones K, Harvey A, Haworth CS, Hiscocks E, Hurst JR, Johnson C, Kelleher PW, Bedi P, Payne K, Saleh H, Screaton NJ, Smith M, Tunney M, Whitters D, Wilson R, Loebinger MR.

Thorax. 2019 Jan;74(Suppl 1):1-69. doi: 10.1136/thoraxjnl-2018-212463. No abstract available.

PMID:
30545985
30.

The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD.

Flynn RWV, MacDonald TM, Chalmers JD, Schembri S.

Respir Res. 2018 Dec 12;19(1):249. doi: 10.1186/s12931-018-0960-3.

31.

Economic burden of bronchiectasis in Germany.

Diel R, Chalmers JD, Rabe KF, Nienhaus A, Loddenkemper R, Ringshausen FC.

Eur Respir J. 2019 Feb 28;53(2). pii: 1802033. doi: 10.1183/13993003.02033-2018. Print 2019 Feb.

PMID:
30523162
32.

New Insights Into the Epidemiology of Bronchiectasis.

Chalmers JD.

Chest. 2018 Dec;154(6):1272-1273. doi: 10.1016/j.chest.2018.08.1051. No abstract available.

PMID:
30526964
33.

ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training.

Aliberti S, Farr A, Tabin N, Blasi F, Torres A, Woodhead M, Migliori GB, Sotgiu G, Dimopoulos G, Chalmers JD, Ringshausen FC, Loebinger MR, Read R, Rohde G.

Breathe (Sheff). 2018 Dec;14(4):269-275. doi: 10.1183/20734735.026218.

34.

Quality control for multiple breath washout tests in multicentre bronchiectasis studies: Experiences from the BRONCH-UK clinimetrics study.

O'Neill K, Lakshmipathy GR, Ferguson K, Cosgrove D, Hill AT, Loebinger MR, Carroll M, Chalmers JD, Gatheral T, Johnson C, DeSoyza A, Hurst JR, Bradbury I, Elborn JS, Bradley JM.

Respir Med. 2018 Dec;145:206-211. doi: 10.1016/j.rmed.2018.10.030. Epub 2018 Nov 1.

PMID:
30509710
35.

A comprehensive approach to lung function in bronchiectasis.

Radovanovic D, Santus P, Blasi F, Sotgiu G, D'Arcangelo F, Simonetta E, Contarini M, Franceschi E, Goeminne PC, Chalmers JD, Aliberti S.

Respir Med. 2018 Dec;145:120-129. doi: 10.1016/j.rmed.2018.10.031. Epub 2018 Nov 2.

PMID:
30509700
36.

Bisphenol A Alters Bmal1, Per2, and Rev-Erba mRNA and Requires Bmal1 to Increase Neuropeptide Y Expression in Hypothalamic Neurons.

Loganathan N, Salehi A, Chalmers JA, Belsham DD.

Endocrinology. 2019 Jan 1;160(1):181-192. doi: 10.1210/en.2018-00881.

PMID:
30500912
37.

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials.

Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A; Blood Pressure Lowering Treatment Trialists’ Collaboration.

J Hypertens. 2019 Jan;37(1):16-23. doi: 10.1097/HJH.0000000000001994.

PMID:
30499920
38.

Management of cellulitis: current practice and research questions.

Santer M, Lalonde A, Francis NA, Smart P, Hooper J, Teasdale E, Del Mar C, Chalmers JR, Thomas KS.

Br J Gen Pract. 2018 Dec;68(677):595-596. doi: 10.3399/bjgp18X700181. No abstract available.

PMID:
30498163
39.

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration.

Aliberti S, Polverino E, Chalmers JD, Altenburg J, Shteinberg M, Goeminne PC, Welte T, Shoemark A, Almagro M, Blasi F; EMBARC Clinical Research Collaboration.

Eur Respir J. 2018 Nov 29;52(5). pii: 1802074. doi: 10.1183/13993003.02074-2018. Print 2018 Nov. No abstract available.

PMID:
30498055
40.

Patients' understanding of cellulitis and views about how best to prevent recurrent episodes: mixed-methods study in primary and secondary care.

Teasdale EJ, Lalonde A, Muller I, Chalmers J, Smart P, Hooper J, El-Gohary M, Thomas KS, Santer M.

Br J Dermatol. 2018 Nov 19. doi: 10.1111/bjd.17445. [Epub ahead of print]

PMID:
30451281
41.

Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial.

Chalmers JD, Djamin RS, Schouten M, Keir HR, Tan B, Aerts JGJV, Huang JT, van der Eerden M.

ERJ Open Res. 2018 Nov 12;4(4). pii: 00136-2018. doi: 10.1183/23120541.00136-2018. eCollection 2018 Oct.

42.

Bronchiectasis.

Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ.

Nat Rev Dis Primers. 2018 Nov 15;4(1):45. doi: 10.1038/s41572-018-0042-3. Review.

PMID:
30442957
43.

The use of infrared thermography in the measurement and characterization of brown adipose tissue activation.

Law J, Chalmers J, Morris DE, Robinson L, Budge H, Symonds ME.

Temperature (Austin). 2018 Jan 29;5(2):147-161. doi: 10.1080/23328940.2017.1397085. eCollection 2018. Review.

44.

Palmitate Induces an Anti-Inflammatory Response in Immortalized Microglial BV-2 and IMG Cell Lines that Decreases TNFα Levels in mHypoE-46 Hypothalamic Neurons in Co-Culture.

Kim SM, McIlwraith EK, Chalmers JA, Belsham DD.

Neuroendocrinology. 2018;107(4):387-399. doi: 10.1159/000494759. Epub 2018 Oct 23.

PMID:
30352432
45.

How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis.

Terranova L, Oriano M, Teri A, Ruggiero L, Tafuro C, Marchisio P, Gramegna A, Contarini M, Franceschi E, Sottotetti S, Cariani L, Bevivino A, Chalmers JD, Aliberti S, Blasi F.

Int J Mol Sci. 2018 Oct 20;19(10). pii: E3256. doi: 10.3390/ijms19103256.

46.

Statistical analysis plan for evaluating different intensities of blood pressure control in the ENhanced Control of Hypertension And Thrombolysis strokE stuDy.

Anderson CS, Woodward M, Arima H, Chen X, Lindley RI, Wang X, Chalmers J, Robinson TG.

Int J Stroke. 2018 Oct 9:1747493018806170. doi: 10.1177/1747493018806170. [Epub ahead of print]

PMID:
30299230
47.

NIHSS cut point for predicting outcome in supra- vs infratentorial acute ischemic stroke.

Yoshimura S, Lindley RI, Carcel C, Sato S, Delcourt C, Wang X, Chalmers J, Anderson CS; ENCHANTED Investigators.

Neurology. 2018 Oct 30;91(18):e1695-e1701. doi: 10.1212/WNL.0000000000006437. Epub 2018 Sep 28.

PMID:
30266885
48.

Distinct 'Immuno-Allertypes' of Disease and High Frequencies of Sensitisation in Non-Cystic-Fibrosis Bronchiectasis.

Mac Aogáin M, Tiew PY, Lim AYH, Low TB, Tan GL, Hassan T, Ong TH, Pang SL, Lee ZY, Gwee XW, Martinus C, Sio YY, Matta SA, Ong TC, Tiong YS, Wong KN, Narayanan S, Bijin Au V, Marlier D, Keir HR, Tee A, Abisheganaden JA, Koh MS, Wang Y, Connolly JE, Chew FT, Chalmers JD, Chotirmall SH.

Am J Respir Crit Care Med. 2018 Sep 28. doi: 10.1164/rccm.201807-1355OC. [Epub ahead of print]

PMID:
30265843
49.

A systematic review of clinical trial registration in major respiratory journals 2010-2018.

Suntila NSM, Smith A, Al-Dabbagh Y, Chalmers JD.

Eur Respir J. 2018 Dec 6;52(6). pii: 1801491. doi: 10.1183/13993003.01491-2018. Print 2018 Dec. No abstract available.

PMID:
30262578
50.

Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals.

Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, Ost DE, Punjabi NM, Schatz M, Smyth AR, Stewart PW, Suissa S, Adjei AA, Akdis CA, Azoulay É, Bakker J, Ballas ZK, Bardin PG, Barreiro E, Bellomo R, Bernstein JA, Brusasco V, Buchman TG, Chokroverty S, Collop NA, Crapo JD, Fitzgerald DA, Hale L, Hart N, Herth FJ, Iwashyna TJ, Jenkins G, Kolb M, Marks GB, Mazzone P, Moorman JR, Murphy TM, Noah TL, Reynolds P, Riemann D, Russell RE, Sheikh A, Sotgiu G, Swenson ER, Szczesniak R, Szymusiak R, Teboul JL, Vincent JL.

Ann Am Thorac Soc. 2019 Jan;16(1):22-28. doi: 10.1513/AnnalsATS.201808-564PS. No abstract available. Erratum in: Ann Am Thorac Soc. 2019 Feb;16(2):283.

PMID:
30230362

Supplemental Content

Loading ...
Support Center